IMMUNOMODULATOR AND PHARMACEUTICAL COMPOSITIONS WITH ANTITUMOR PROPERTIES, AND A FOOD ADDITIVE

摘要

The invention proposes the use of alpha and/or beta -glycosides N-acetylmuramil-L-alanyl-D-isoglutamine /CH3-/CH2/n-muramildipeptide (MDP) as an immunomodulator, as well as pharmaceutical compositions with antitumor properties that include an effective quantity of alpha and/or beta -glycosides muramildipeptide (MDP) and physiologically acceptable carriers. The dosage of the active ingredient in the form of a drug is of 0.0001-100 mg/kg in weight when administered perorally, of 0.00001-30 mg/kg in weight when administered intravenously, and of 0.00001-10 mg/kg in weight in the case of a lyposomal administration. This invention also relates to a preparation formulated on the basis of alpha and/or beta -glycosides MDP/CH3-/CH2/n-MDP/ which activates the main immunity bonds. The invention further proposes the use of alpha and/or beta -glycosides N-acetylmuramil-L-alanyl-D-isoglutamine as a food additive.